Cargando…

USP10 as a Potential Therapeutic Target in Human Cancers

Deubiquitination is a major form of post-translational protein modification involved in the regulation of protein homeostasis and various cellular processes. Deubiquitinating enzymes (DUBs), comprising about five subfamily members, are key players in deubiquitination. USP10 is a USP-family DUB featu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Li, Liu, Xiao, Jiang, Xinya, Zhang, Kun, Wang, Yijing, Li, Xiumin, Jiang, Shulong, Han, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142050/ https://www.ncbi.nlm.nih.gov/pubmed/35627217 http://dx.doi.org/10.3390/genes13050831

Ejemplares similares

The Prognostic Value and Immune Infiltration of USP10 in Pan-Cancer: A Potential Therapeutic Target
por: Gao, Dacheng, et al.
Publicado: (2022)

USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target
por: Wang, Yizhi, et al.
Publicado: (2020)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

Pan-cancer analysis combined with experiments predicts CTHRC1 as a therapeutic target for human cancers
por: Peng, Dazhao, et al.
Publicado: (2021)

USP15 in Cancer and Other Diseases: From Diverse Functionsto Therapeutic Targets
por: Li, Yan-Chi, et al.
Publicado: (2022)

An association study between USP34 and polycystic ovary syndrome
por: Zhao, Shigang, et al.
Publicado: (2015)

Ferroptosis as a potential target for cancer therapy
por: Chen, Zhen, et al.
Publicado: (2023)

Insight into the physiological and pathological roles of USP44, a potential tumor target (Review)
por: Lou, Yuming, et al.
Publicado: (2022)

Association and clinical implication of the USP10 and MSH2 proteins in non-small cell lung cancer
por: Zeng, Zhi, et al.
Publicado: (2019)

Targeting deubiquitinase USP28 for cancer therapy
por: Wang, Xiaofang, et al.
Publicado: (2018)

USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma
por: Qiu, Wenjin, et al.
Publicado: (2023)

DAB2IP suppresses invadopodia formation through destabilizing ALK by interacting with USP10 in breast cancer
por: Huang, Qingwen, et al.
Publicado: (2023)

USP10 deubiquitinates Tau, mediating its aggregation
por: Wei, Zhen, et al.
Publicado: (2022)

USP32 deubiquitinase: cellular functions, regulatory mechanisms, and potential as a cancer therapy target
por: Li, Shuang, et al.
Publicado: (2023)

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma
por: Cao, Yu-Fei, et al.
Publicado: (2022)

Usp10 Modulates the Hippo Pathway by Deubiquitinating and Stabilizing the Transcriptional Coactivator Yorkie
por: Gao, Yang, et al.
Publicado: (2019)

USP37 downregulation elevates the Chemical Sensitivity of Human Breast Cancer Cells to Adriamycin
por: Qin, Tao, et al.
Publicado: (2021)

USP14 promotes colorectal cancer progression by targeting JNK for stabilization
por: Du, Xue-Hua, et al.
Publicado: (2023)

USP25 promotes pathological HIF-1-driven metabolic reprogramming and is a potential therapeutic target in pancreatic cancer
por: Nelson, Jessica K., et al.
Publicado: (2022)

Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy
por: Cui, Shu‐Zhong, et al.
Publicado: (2020)

Identification of the mitochondrial protein POLRMT as a potential therapeutic target of prostate cancer
por: Li, Xiaojun, et al.
Publicado: (2023)

KIF15 is essential for USP10-mediated PGK1 deubiquitination during the glycolysis of pancreatic cancer
por: Quan, Gang, et al.
Publicado: (2023)

Strategies to Target ISG15 and USP18 Toward Therapeutic Applications
por: Jiménez Fernández, Daniel, et al.
Publicado: (2020)

USP10 Targeted Self-Deliverable siRNA to Prevent Scarring in the Cornea
por: Boumil, Edward F., et al.
Publicado: (2020)

Inhibition of USP7 suppresses advanced glycation end-induced cell cycle arrest and senescence of human umbilical vein endothelial cells through ubiquitination of p53: USP7 inhibits ubiquitination of p53
por: Li, Xu, et al.
Publicado: (2022)

Role and mechanism of programmed death-ligand 1 in hypoxia-induced liver cancer immune escape
por: Wen, Qingxian, et al.
Publicado: (2020)

Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin
por: Tang, Zheng, et al.
Publicado: (2021)

USP7: Novel Drug Target in Cancer Therapy
por: Wang, Zhiru, et al.
Publicado: (2019)

Subunits of human condensins are potential therapeutic targets for cancers
por: Wang, Hong-Zhen, et al.
Publicado: (2018)

USP9X expression is functionally related to laryngeal cancer
por: Wan, Yu-feng, et al.
Publicado: (2023)

Interleukin-17 as a potential therapeutic target for chronic pain
por: Jiang, Xiaojuan, et al.
Publicado: (2022)

Inhibition of the deubiquitinase USP10 induces degradation of SYK
por: Yang, Jing, et al.
Publicado: (2020)

Neutrophils in pancreatic cancer: Potential therapeutic targets
por: Jiang, Wenkai, et al.
Publicado: (2022)

Inhibition of USP7 upregulates USP22 and activates its downstream cancer-related signaling pathways in human cancer cells
por: Zhang, Keqiang, et al.
Publicado: (2023)

Myostatin: a potential therapeutic target for metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)

Identification and Characterization of USP7 Targets in Cancer Cells
por: Georges, Anna, et al.
Publicado: (2018)

USP10 Promotes Fibronectin Recycling, Secretion, and Organization
por: Phillips, Andrew T., et al.
Publicado: (2021)

A Horizontal-Gate Monolayer MoS(2) Transistor Based on Image Force Barrier Reduction
por: Yang, Kun, et al.
Publicado: (2019)

Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer
por: Liang, Yiran, et al.
Publicado: (2019)

USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy
por: Xiong, Wenjun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_861igiqn8lflnaochu0n6p5k6m